Find the right fit for you - faster
Get tailored insights about working at Replimune in one quick step.
Replimune Snapshot
Transforming the lives of cancer patients through the development of highly effective but low toxicity therapies that provide durable benefit across a broad range of tumor types
Replimune is a biotechnology firm that develops oncolytic immuno-gene therapies to treat cancer. The powerful Immulytic™ platform combines multiple mechanisms to deliver medicines with the ability to not only directly kill cancer cells, but also create a practical approach to achieving personalized systemic neoantigen vaccination directly in the patient.
